Great! You have sucessfully subscribed for newsletters for investments
Knowing this helps you control risk in your portfolio
Determine this by answering these simple questions.
NAV as of ( Sep 09, 2022 )
₹ 302.85 -0.05 % 1-D Change
You get upto 0.92% extra returns
ET Money Rank
Not yet ranked
Generated returns consistently
Increased returns for each unit of additional risk
Controlled losses during market corrections
Delivered returns without frequent ups and downs
Sign-up for free to view fund's Report Card
Select SIP date
How long should this SIP run?
Fresh Investments closed in this fund!
This fund is no longer available to invest
|ET Money Rank||Not yet ranked|
|Expense ratio||1.06% As on Jul 31, 2022|
|AUM (Fund Size)||₹ 4,588 Crs|
|Age||9 yrs 8 m Since Jan 01, 2013|
|Benchmark||S&P BSE Healthcare TRI|
SIP ₹ 100 &
Lumpsum ₹ 5000
Answer a few simple questions and understand why you take the financial decisions you do.
You would have earned ₹ 1,001 more by investing in ET Money Direct Plan
Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully. Past performance is not an indicator of future returns.
Large Cap 49.41%
Mid Cap 28.12%
Small Cap 22.15%
Other Cap 0%
Bifurcation by Holding is not available for this fund
Bifurcation by Credit Quality is not available for this fund
Know in detail about the portfolio of this fund See detailed Portfolio Analysis
|Fund name||Annual Return %||Consistency||Value Research Rating|
|Nippon India Pharma Fund||18.29%|
|Tata India Pharma & HealthCare Fund||16.85%|
|UTI Healthcare Fund||13.95%|
|SBI Healthcare Opportunities Fund||13.45%|
Sign-up for free to compare fund with sectoral-pharma funds
|Period||Trailing returns||Category average||Rank within category|
|1 month||0.21%||0.53%||5 / 8|
|3 months||7.56%||7.78%||4 / 8|
|6 months||-2%||-1.62%||5 / 8|
|1 year||-10.05%||-9.71%||4 / 8|
|3 years||26.05%||25.82%||4 / 8|
|5 years||18.29%||15.64%||1 / 4|
Know in detail about the returns of this fund See detailed Return Analysis
Level of Risk in the Scheme
Investors understand that their principal will be at Very High risk
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
As on Jun 30, 2022
The Nippon India Pharma Fund is a 9 yrs 8 m old fund and has delivered average annual returns of 16.33% since inception.
NAV or Net Asset Value is the per-unit price of the Mutual Fund. The NAV of a Mutual Fund changes every day. It is calculated by taking the current value of the holdings of the fund at end of the day, subtracting the expenses, and dividing the value by the number of units issued to date.
The NAV of Nippon India Pharma Fund for Sep 09, 2022 is 302.85 .
On ET Money, Investing in Nippon India Pharma Fund is fast, easy, and 100% paperless. And it takes only minutes. Here is what you need to do -
The Expense Ratio of a Mutual Fund is the annual charges you pay to the Mutual Fund company for managing your investments in that fund. The Expense Ratio is a percentage of Assets Under Management (AUM) and is taken from the returns generated by the fund. For this reason, a fund with a lower expense ratio is always better because a smaller part of the returns will be taken and that means more returns for you.
The Expense Ratio of the direct plan of Nippon India Pharma Fund is 1.06%. .
Redeeming your investments in Nippon India Pharma Fund is super easy. If you have invested in this fund via ET Money, just login into the app, go to the investment section and put the redemption request.
If you have invested in Nippon India Pharma Fund from anywhere else, you can go to the fund house website and put a request through it.
AUM or Asset Under Management is the total value of the assets held by a Mutual Fund scheme. For instance, for an equity Mutual Fund, the AUM will be the total value of its portfolio's equity shares (plus any other asset it might have invested in). The AUM of the fund changes every day because the price of the underlying asset fluctuates daily. However, the Mutual Fund company doesn't update it every day. It is updated only at the end of the month and released within few days of the next month.
The AUM of the fund is a good indicator of its popularity. A fund with a high AUM means a lot of money has been invested in it, and investors like it. However, the AUM should never be the primary criteria while selecting a fund. There are funds with huge AUMs that continue to perform well despite their size.
The AUM of Nippon India Pharma Fund is ₹4,588 Crs.
The Nippon India Pharma Fund has invested the majority of its money in the stocks of the following companies -
|Company||Percentage of Portfolio|
|Sun Pharmaceutical Inds. Ltd.||14.21%|
|Dr. Reddy's Laboratories Ltd.||7.87%|
|Torrent Pharmaceuticals Ltd.||6.42%|
|Divi's Laboratories Ltd.||5.93%|
|Narayana Hrudayalaya Ltd.||5.64%|
|Abbott India Ltd.||5.28%|
|Aurobindo Pharma Ltd.||4.16%|
|Fortis Healthcare (India) Ltd||3.85%|
The Nippon India Pharma Fund has primarily invested in the following sectors
|Sector||Percentage of Portfolio|